Sulphonylurea monotherapy for patients with type 2 diabetes mellitus

Bianca Hemmingsen, Jeppe B Schroll, Søren Lund, Jørn Wetterslev, Christian Gluud, Allan Vaag, David Peick Sonne, Lars Hyldborg Lundstrøm, Thomas Almdal

60 Citationer (Scopus)

Abstract

Type 2 diabetes mellitus (T2DM) is a growing health problem worldwide. Whether sulphonylureas show better, equal or worse therapeutic effects in comparison with other antidiabetic interventions for patients with T2DM remains controversial.
OriginalsprogEngelsk
TidsskriftCochrane Database of Systematic Reviews
Vol/bind4
Sider (fra-til)CD009008
ISSN1469-493X
DOI
StatusUdgivet - 2013

Fingeraftryk

Dyk ned i forskningsemnerne om 'Sulphonylurea monotherapy for patients with type 2 diabetes mellitus'. Sammen danner de et unikt fingeraftryk.

Citationsformater